Capital Group Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.14M	Sell	6,474 -8,372	-56%	-$2.85M	0.37%	74
2025 Q4	$5.9M	Sell	14,846 -2,017	-12%	-$893K	0.96%	28
2025 Q3	$7.69M	Sell	16,863 -875	-5%	-$356K	1.29%	18
2025 Q2	$5.78M	Buy	17,738 +388	+2%	+$107K	1.03%	25
2025 Q1	$4.68M	Buy	17,350 +179	+1%	+$46K	0.96%	31
2024 Q4	$4.04M	Sell	17,171 -4,176	-20%	-$1.1M	0.77%	35
2024 Q3	$5.87M	Buy	21,347 +1,777	+9%	+$463K	1.18%	23
2024 Q2	$4.76M	Buy	19,570 +3,397	+21%	+$536K	1.03%	27
2024 Q1	$2.42M	Sell	16,173 -16,251	-50%	-$2.71M	0.43%	69
2023 Q4	$6.21M	Sell	32,424 -21,092	-39%	-$3.59M	0.65%	48
2023 Q3	$9.48M	Buy	53,516 +34,048	+175%	+$6.5M	0.62%	68
2023 Q2	$3.7M	Hold	19,468	–	–	0.18%	96
2023 Q1	$3.9M	Sell	19,468 -2,582	-12%	-$543K	0.21%	96
2022 Q4	$5.24M	Buy	+22,050	New	+$4.7M	0.2%	90